Breast Cancer Research and Treatment

, Volume 93, Issue 1, pp 91–95 | Cite as

Primary Malignancy after Primary Female Breast Cancer in the South of the Netherlands, 1972–2001

  • I. Soerjomataram
  • W. J. Louwman
  • E. de Vries
  • V. E. P. P. Lemmens
  • W. J. Klokman
  • J. W. W. Coebergh


Objectives. To assess the risk of second primary cancers among women with previous breast cancer and calculate the excess burden of second cancer in the population.

Methods. A population-based longitudinal study was conducted using the Eindhoven cancer registry data on 9919 breast cancer patients diagnosed in the period 1972–2000 and followed until 2001. Standardised incidence ratios (SIR) and absolute excess risks (AER) were calculated.

Results. In total, 1298 (13%) women developed a second primary cancer. The risk of overall second cancer was higher among breast cancer patients compared to the general population (SIR: 2.8; 95% CI: 2.6–2.9), with an AER of 115 second cancers for every 10,000 breast cancer patients per year. High SIR and AER were observed for breast cancer (SIR: 4.1; 95% CI: 3.8–4.4; AER: 64/10,000 patients/year) and ovarian cancer (SIR: 2.0; 95% CI: 1.5–2.7; AER: 4.5/10,000 patients/year).

Conclusions. Our recent data show that women with previous breast cancer have an elevated risk of developing a second cancer compared to the general population. Excess burden for the population is especially high for second cancers of the breast, ovary and colon. Screening may only be justified for breast, ovary and colon cancer in certain groups of patients.


absolute excess risk breast cancer registry-based study second primary cancer standardised incidence ratio 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Harris, J, Morrow, M, Norton, L 1997

    Malignant tumors of the breast

    DeVita, VTHellman, SRosenberg, AS eds. Cancer: Principles & Practice of Oncology5Lippicott-Raven PublishersPhiladelphia15571616
    Google Scholar
  2. 2.
    Coebergh JWW, Janssen-Heijnen MLG, Louwman WJ, and Voogd␣AC: Cancer incidence, care and survival in the South of Netherlands, 1955–1999: a report of the Eindhoven Cancer Registry (IKZ) with cross-border implications. Eindhoven, The Netherlands; 2001Google Scholar
  3. 3.
    Leeuwen, FE 1997

    Second cancers

    DeVita, VTHellman, SRosenberg, AS eds. Cancer: Principles & Practice of Oncology5Lippicott-Raven PublishersPhiladelphia27732793
    Google Scholar
  4. 4.
    Levi, F, Randimbison, TV, La Vecchia, C 1998Second primary cancers in breast cancer patients in Vaud, SwitzerlandCancer Causes Control9463464CrossRefPubMedGoogle Scholar
  5. 5.
    Volk, N, Pompe-Kirn, V 1997Second primary cancers in breast cancer patients in SloveniaCancer Causes Control8764770CrossRefPubMedGoogle Scholar
  6. 6.
    Brenner, H, Siegle, S, Stegmaier, C, Ziegler, H 1993Second primary neoplasms following breast cancer in Saarland, Germany, 1968–1987Eur J Cancer29A14101414CrossRefPubMedGoogle Scholar
  7. 7.
    Murakami, R, Hiyama, T, Hanai, A, Fujimoto, I 1987Second primary cancers following female breast cancer in Osaka, Japan – a population-based cohort studyJpn J Clin Oncol17293302PubMedGoogle Scholar
  8. 8.
    Rubino, C, de Vathaire, F, Diallo, I, Shamsaldin, A, Le, MG 2000Increased risk of second cancers following breast cancer: role of the initial treatmentBreast Cancer Res Treat61183195CrossRefPubMedGoogle Scholar
  9. 9.
    Ewertz, M, Mouridsen, HT 1985Second cancer following cancer of the female breast in Denmark, 1943–80Natl Cancer Inst Monogr68325329PubMedGoogle Scholar
  10. 10.
    Horn-Ross, PL, Ljung, BM, Morrow, M 1997Environmental factors and the risk of salivary gland cancerEpidemiology8414419CrossRefPubMedGoogle Scholar
  11. 11.
    Levi, F, Te, V-C, Randimbison, L, La Vecchia, C 2003Cancer risk in women with previous breast cancerAnn Oncol147173CrossRefPubMedGoogle Scholar
  12. 12.
    Rubino, C, de Vathaire, F, Shamsaldin, A, Labbe, M, Le, MG 2003Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatmentBr J Cancer89840846CrossRefPubMedGoogle Scholar
  13. 13.
    Mattsson, A, Hall, P, Ruden, BI, Rutqvist, LE 1997Incidence of primary malignancies other than breast cancer among women treated with radiation therapy for benign breast diseaseRadiat Res148152160PubMedGoogle Scholar
  14. 14.
    Harvey, EB, Brinton, LA 1985Second cancer following cancer of the breast in Connecticut, 1935–82Natl Cancer Inst Monogr6899112PubMedGoogle Scholar
  15. 15.
    Shapiro, CL, Recht, A 2001Side effects of adjuvant treatment of breast cancerN Engl J Med34419972008CrossRefPubMedGoogle Scholar
  16. 16.
    Adami, HO, Bergkvist, L, Krusemo, U, Persson, I 1984Breast cancer as a risk factor for other primary malignant diseases. A nationwide cohort studyJ Natl Cancer Inst7310491055Google Scholar
  17. 17.
    Newcomb, PA, Solomon, C, White, E 1999Tamoxifen and risk of large bowel cancer in women with breast cancerBreast Cancer Res Treat53271277CrossRefPubMedGoogle Scholar
  18. 18.
    Newschaffer, CJ, Topham, A, Herzberg, T, Weiner, S, Weinberg, DS 2001Risk of colorectal cancer after breast cancerLancet357837840CrossRefPubMedGoogle Scholar
  19. 19.
    Li, CI, Rossing, MA, Voigt, LF, Daling, JR 2000Multiple primary breast and thyroid cancers: role of age at diagnosis and cancer treatmentsCancer Causes Control11805811CrossRefPubMedGoogle Scholar
  20. 20.
    Teppo, L, Pukkala, E, Saxen, E 1985Multiple cancer – an epidemiologic exercise in FinlandJ Natl Cancer Inst75207217PubMedGoogle Scholar
  21. 21.
    Leeuwen, FE, Klokman, WJ, Hagenbeek, A, Nozon, R, Belt-Dusenbout, AW, Kerkhoff, EH, Heerde, P, Somers, R 1994Second cancer risk following Hodgkinȁ9s disease: a 20-year follow up studyJ Clin Oncol12312325PubMedGoogle Scholar
  22. 22.
    Soerjomataram I, Louwman WJ, Lemmens VEPP, de Vries E, Klokman WJ, Coebergh JWW: Risks of second primary breast and urogenital cancer following female breast cancer in the south of the Netherlands, 1972–2001. Eur J Cancer, in press Google Scholar
  23. 23.
    Breslow NE, Day NE: Statistical methods in cancer research, Volume II – The design and analysis of cohort studies. IARC Sci Publ 1–406, 1987Google Scholar
  24. 24.
    Ozols, RF, Schwartz, PE, Eifel, PJ 1997

    Ovarian cancer, fallopian tube carcinoma, and peritoneal carcinoma

    Vita, VTHellman, SRosenberg, AS eds. Cancer: Principles & Practice of Oncology5Lippincott-Raven PublishersPhiladephia15021539
    Google Scholar
  25. 25.
    Arver, B, Du, Q, Chen, J, Luo, L, Lindblom, A 2000Hereditary breast cancer: a reviewSemin Cancer Biol10271288Google Scholar
  26. 26.
    Hemminki, K, Vaittinen, P, Easton, D 2000Familial cancer risks to offspring from mothers with 2 primary breast cancers: leads to cancer syndromesInt J Cancer888791CrossRefPubMedGoogle Scholar
  27. 27.
    Li, FP, Fraumeni, JF,Jr. 1969Soft tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?Ann Intern Med71747752PubMedGoogle Scholar
  28. 28.
    Dhillon, PK, Farrow, DC, Vaughan, TL, Chow, WH, Risch, HA, Gammon, MD, Mayne, ST, Stanford, JL, Schoenberg, JB, Ahsan, H,  et al. 2001Family history of cancer and risk of esophageal and gastric cancers in the United StatesInt J Cancer93148152CrossRefPubMedGoogle Scholar
  29. 29.
    Ron, E 2003Cancer risks from medical radiationHealth Phys854759CrossRefPubMedGoogle Scholar
  30. 30.
    Curtis, RE, Boice, JD,Jr., Shriner, DA, Hankey, BF, Fraumeni, JF,Jr. 1996Second cancers after adjuvant tamoxifen therapy for breast cancerJ Natl Cancer Inst88832834PubMedGoogle Scholar
  31. 31.
    Fisher, B, Costantino, JP, Wickerham, DL, Redmond, CK, Kavanah, M, Cronin, WM, Vogel, V, Robidoux, A, Dimitrov, N, Atkins, J,  et al. 1998Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJ␣Natl Cancer Inst9013711388CrossRefPubMedGoogle Scholar
  32. 32.
    Rutqvist, LE, Johansson, H, Signomklao, T, Johansson, U, Fornander, T, Wilking, N 1995Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study GroupJ Natl Cancer Inst87645651PubMedGoogle Scholar
  33. 33.
    Leeuwen, FE, Benraadt, J, Coebergh, JW, Kiemeney, LA, Gimbrere, CH, Otter, R, Schouten, LJ, Damhuis, RA, Bontenbal, M, Diepenhorst, FW,  et al. 1994Risk of endometrial cancer after tamoxifen treatment of breast cancerLancet343448452CrossRefPubMedGoogle Scholar
  34. 34.
    Fornander, T, Rutqvist, LE, Cedermark, B, Glas, U, Mattsson, A, Silfversward, C, Skoog, L, Somell, A, Theve, T, Wilking, N,  et al. 1989Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancersLancet1117120CrossRefPubMedGoogle Scholar
  35. 35.
    Barrett, JC, Davis, BJ, Bennett, LM 2003Pregnancy and protection from hormonally associated tumor developmentEpidemiology14139140CrossRefPubMedGoogle Scholar
  36. 36.
    Lumachi, F, Ermani, M, Brandes, AA, Basso, U, Paris, M, Basso, SM, Boccagni, P 2002Breast cancer risk in healthy and symptomatic women: results of a multivariate analysis. A case–control studyBiomed Pharmacother56416420CrossRefPubMedGoogle Scholar
  37. 37.
    Thomson, CA, Flatt, SW, Rock, CL, Ritenbaugh, C, Newman, V, Pierce, JP 2002Increased fruit, vegetable and fiber intake and lower fat intake reported among women previously treated for invasive breast cancerJ Am Diet Assoc102801808CrossRefPubMedGoogle Scholar
  38. 38.
    Levi, F, Pasche, C, Lucchini, F, La Vecchia, C 2001Dietary fibre and the risk of colorectal cancerEur J Cancer3720912096CrossRefPubMedGoogle Scholar
  39. 39.
    Goggins, W, Gao, W, Tsao, H 2004Association between female breast cancer and cutaneous melanomaInt J Cancer111792794CrossRefPubMedGoogle Scholar
  40. 40.
    Hehir, DJ, Dawson, KJ, Parbhoo, SP 1992Primary breast carcinoma in patients with malignant melanomaEur J Surg Oncol187779PubMedGoogle Scholar
  41. 41.
    Braud, F, Khayat, D, Kroon, BBR, Valdagni, R, Bruzzi, P, Cascinelli, N 2003Malignant melanomaCrit Rev Oncol Hematol473563PubMedGoogle Scholar
  42. 42.
    Holly, EA, Cress, RD, Ahn, DK 1994Cutaneous melanoma in women: ovulatory life, menopause and use of exogenous estrogensCancer Epidemiol Biomarkers Prev3661668PubMedGoogle Scholar
  43. 43.
    Sigurdson, AJ, Doody, MM, Rao, RS, Freedman, DM, Alexander, BH, Hauptmann, M, Mohan, AK, Yoshinaga, S, Hill, DA, Tarone, R,  et al. 2003Cancer incidence in the US radiologic technologists health study, 1983–1998Cancer9730803089CrossRefPubMedGoogle Scholar
  44. 44.
    Boice, JD,Jr., Harvey, EB, Blettner, M, Stovall, M, Flannery, JT 1992Cancer in the contralateral breast after radiotherapy for breast cancerN Engl J Med326781785PubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • I. Soerjomataram
    • 1
  • W. J. Louwman
    • 2
  • E. de Vries
    • 3
  • V. E. P. P. Lemmens
    • 2
  • W. J. Klokman
    • 4
  • J. W. W. Coebergh
    • 2
    • 3
  1. 1.Netherlands Institute of Health SciencesRotterdamThe Netherlands
  2. 2.Comprehensive Cancer Center, South/ Eindhoven Cancer RegistryEindhovenThe Netherlands
  3. 3.Department of Public HealthErasmus University Medical CenterRotterdamThe Netherlands
  4. 4.Department of EpidemiologyNetherlands Cancer InstituteAmsterdamThe Netherlands

Personalised recommendations